NIB shares edge higher on profit update

Let's see why this private health insurer is in the news today.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • NIB shares are on the move as investors react to updates on profit expectations, with non-recurring one-off expenses impacting the statutory operating profit but leaving underlying profit unchanged.
  • The company is facing higher than anticipated non-recurring expenses, including $21.5 million related to mergers, acquisitions, and adjustments to previous claims under the Australian Government Rebate and NSW Hospital Insurance Levy.
  • Despite these expenses, NIB is on target with its underlying operating profit expectations, bolstered by strategic consolidations and technology integrations across its acquired NDIS-related businesses.

NIB Holdings Limited (ASX: NHF) shares are edging higher on Friday.

In morning trade, the private health insurer's shares are up almost 1% to $6.96.

Health professional working on his laptop.

Image source: Getty Images

What's going on with NIB shares today?

Investors have been buying the company's shares today after it released an update on its profit expectations.

According to the release, it expects to report non-recurring one-off items that will impact its statutory operating profit (SOP) but not its underlying operating profit (UOP).

The company advised that non-recurring cash expenses in first half are expected to be around $17 million, which is higher than previously indicated at its FY 2025 results briefing in August.

Its one-off and non-recurring expenses, including M&A and integration costs, were $21.5 million for the half. These expenses partly relate to a net cash expense (before tax) of approximately ~$8 million relating to historical adjustments for the Private Health Insurance Australian Government Rebate (AGR) and NSW Hospital Insurance Levy (HIL).

With respect to the AGR, NIB highlights that the Department of Health, Disability and Ageing has recently clarified that the AGR could not be claimed on some historical marketing offers and COVID customer givebacks. In response, NIB has amended its approach moving forward.

For HIL, as a result of recent legal determinations, NIB has confirmed that a different basis of calculation can be utilised for the HIL. This includes refunding some historically charged levies and providing some offset to the AGR impact. This approach has also been amended going forward.

Outside this, the company's non-recurring cash expenses include restructuring costs associated with the group-wide productivity program, as well as strategic initiatives such as the strategic review of NIB Travel, with an outcome expected in FY 2026.

What else?

NIB also revealed that a non-cash expense (before tax) of around $4.5 million is expected to be incurred in the first half. This is for the reduction in the value of redundant acquired software relating to acquisitions in NIB Thrive.

Management advised that this will be recognised in the amortisation of acquired intangibles.

Since 2022, the company has acquired six NDIS plan management businesses, a support coordination business, and an NDIS marketplace platform.

Over the last 12 months, it has consolidated the majority of these businesses onto a single technology platform to enhance automation, operating efficiency, and ongoing business model simplification.

Underlying profit on target

While we are not quite at the end of the half, management highlights that it is currently performing to expectations for group UOP during the first half. Though, it acknowledges that this is subject to the second quarter risk equalisation outcome.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A scientist examining test results.
Healthcare Shares

CSL shares are up 35% since early June. Is the recovery here to stay?

Can CSL shares continue their comeback?

Read more »

patient with doctor, medical company, medical insurance
Healthcare Shares

Where could CSL shares go next? Here's what brokers are predicting

Brokers see long-term value despite differing views on near-term upside.

Read more »

A small child carrying a brief case tries to reach an elevator button outside closed elevator doors.
Healthcare Shares

Up 1,636%, but can 4DMedical shares reclaim their record high?

Can the US growth story drive the ASX star back to records?

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Healthcare Shares

Mesoblast shares: Q4 earnings top projections

Ryoncil® uptake has exceeded initial projections

Read more »

A woman leans forward with her hands shielding her eyes as if she is looking intently for something.
Healthcare Shares

Up 36%: Can CSL shares keep rebounding?

Find out what experts expect from CSL shares next.

Read more »

A man looking at his laptop and thinking.
Healthcare Shares

Is CSL a fallen ASX giant to buy in July?

Confidence has been shaken, but I think the long-term opportunity remains attractive.

Read more »

A sad looking scientist sitting and upset about a share price fall.
Healthcare Shares

This red-hot ASX healthcare share hit a speed bump. What next?

The tech company must convert innovation into profits to justify its lofty valuation.

Read more »

Two health workers taking a break.
Healthcare Shares

Top broker tips 37% upside for this exciting ASX healthcare stock

This healthcare stock is one to watch.

Read more »